Back

COVID-19 exposure risks and protective measures in East Londons healthcare and academic sectors: Insights and applications of GloBody technology for infectious disease monitoring

2025-04-20 dentistry and oral medicine Title + abstract only
View on medRxiv
Show abstract

The COVID-19 pandemic highlighted the need for effective protection and rapid development of tests to track and quantify seroconversion through natural infection and vaccination. Recombinant proteins, consisting of the SARS-CoV-2 nucleocapsid and Spike Receptor Binding Domains (RBD) fused with nanoluciferase reporters (GloBodies) were designed and produced. The SARS-CoV-2 specific antibody within serum, from venous blood or eluted from local or remotely-obtained dried blood spots, form a complex...

Predicted journal destinations